Olysio FDA Approval History
FDA Approved: Yes (First approved November 22, 2013)
Brand name: Olysio
Generic name: simeprevir
Dosage form: Capsules
Company: Janssen Pharmaceuticals, Inc.
Treatment for: Hepatitis C
Olysio (simeprevir) is a protease inhibitor for the treatment of chronic hepatitis C virus infection.
Development timeline for Olysio
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.